For citations:
Boyko A.N., Davydovskaya M.V., Khachanova N.V., Zakharova M.N., Spirin N.N., Popova E.V., Alifirova V.M., Vlasov Y.V., Sivertseva S.A., Khabirov F.A., Shumilina M.V., Evdoshenko E.P. Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3):16-25. (In Russ.) https://doi.org/10.14412/2074-2711-2019-3-16-25